Timothy O’Brien
Impact in
Papers in
-
- RNA Interference and Gene Delivery 29
- Angiogenesis and VEGF in Cancer 24
- Pluripotent Stem Cells Research 19
- Surgery 75
- Tissue Engineering and Regenerative Medicine 25
- Co-authors
- Frank Barry (49 shared papers)Mary Murphy (21 shared papers)Abhay Pandit (27 shared papers)Zvonimir S. Katušić (33 shared papers)Michael J. Kerin (11 shared papers)Aaron Liew (20 shared papers)Róisín M. Dwyer (9 shared papers)Peter Dockery (22 shared papers)
- Journals
- Stem Cell Research & Therapy (18 papers)Stem Cell Research (15 papers)Mayo Clinic Proceedings (12 papers)Stem Cells (7 papers)Cytotherapy (7 papers)
- Partner nations
- IrelandUnited StatesChina
In The Last Decade
Timothy O’Brien
377 papers receiving 12.7k citations
Peers
Comparison fields: 5 of 191
- Genetics 2.6k
- Aging 173
- Biomaterials 1.1k
- Rehabilitation 452
- Endocrinology, Diabetes and Metabolism 1.1k
Countries citing papers authored by Timothy O’Brien
This map shows the geographic impact of Timothy O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy O’Brien more than expected).
Fields of papers citing papers by Timothy O’Brien
This network shows the impact of papers produced by Timothy O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy O’Brien. The network helps show where Timothy O’Brien may publish in the future.
Co-authors
The 25 scholars most cited alongside Timothy O’Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 384 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 354 | |
| 2 | 2010 | 248 | |
| 3 | 2011 | 247 | |
| 4 | 2011 | 210 | |
| 5 | 2018 | 189 | |
| 6 | 2011 | 175 | |
| 7 | 2001 | 175 | |
| 8 | 2006 | 175 | |
| 9 | 1993 | 161 | |
| 10 | 1998 | 159 | |
| 11 | 2015 | 158 | |
| 12 | 2008 | 152 | |
| 13 | 2010 | 150 | |
| 14 | Overexpression of HER-2/neu in uterine serous papillary cancer. | 2002 | 143 |
| 15 | 2009 | 137 | |
| 16 | 2006 | 136 | |
| 17 | 2012 | 132 | |
| 18 | 2020 | 132 | |
| 19 | 2009 | 118 | |
| 20 | 2000 | 118 |
About Timothy O’Brien
Timothy O’Brien is a scholar working on Molecular Biology, Surgery, Genetics, Genetics and Endocrinology, Diabetes and Metabolism, having authored 384 papers that have together received 13.1k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (67 papers), Virus-based gene therapy research (35 papers), Nitric Oxide and Endothelin Effects (30 papers), RNA Interference and Gene Delivery (29 papers), Electrospun Nanofibers in Biomedical Applications (27 papers), Tissue Engineering and Regenerative Medicine (25 papers), Angiogenesis and VEGF in Cancer (24 papers) and Pluripotent Stem Cells Research (19 papers). The work is most often cited by research in Genetics (2.6k citations), Aging (173 citations), Biomaterials (1.1k citations), Rehabilitation (452 citations) and Endocrinology, Diabetes and Metabolism (1.1k citations). Timothy O’Brien has collaborated with scholars based in Ireland, United States and China. Frequent co-authors include Frank Barry, Mary Murphy, Abhay Pandit, Zvonimir S. Katušić, Michael J. Kerin, Aaron Liew, Róisín M. Dwyer, Peter Dockery, Afshin Samali and Tu T. Nguyen. Their work appears in journals such as Stem Cell Research & Therapy, Stem Cell Research, Mayo Clinic Proceedings, Stem Cells and Cytotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.